Back
ProShares UltraShort Nasdaq Biotech Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
41
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
14.28
Seasonality Move:
-4.75%
Sell
42
LBPH
Longboard Pharmaceuticals
Last Price:
33.39
Seasonality Move:
-17.05%
Sell
41
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.58. The Score for BIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Longboard Pharmaceuticals (LBPH)
is a Sell
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $29.31. The Score for LBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $14.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $29.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 43.63 | Sell |
| Chaikin Money Flow: | 4619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.4 - 15.18) | Sell |
| Bollinger Bands (100): | (14.77 - 17.73) | Sell |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.06 | Sell |
| Relative Strength Index (14 RSI): | 38.7 | Sell |
| Chaikin Money Flow: | 434120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.2 - 36.44) | Sell |
| Bollinger Bands (100): | (20.78 - 35.78) | Buy |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.74 | Sell |
| 20-day SMA: | 14.73 | Sell |
| 50-day SMA: | 14.98 | Sell |
| 200-day SMA: | 17.4 | Sell |
| 8-day EMA: | 14.67 | Sell |
| 20-day EMA: | 14.82 | Sell |
| 50-day EMA: | 15.25 | Sell |
| 200-day EMA: | 17.33 | Sell |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.33 | Sell |
| 20-day SMA: | 34.08 | Sell |
| 50-day SMA: | 34.97 | Sell |
| 200-day SMA: | 23.09 | Buy |
| 8-day EMA: | 31.57 | Sell |
| 20-day EMA: | 33.23 | Sell |
| 50-day EMA: | 32.69 | Sell |
| 200-day EMA: | 24.04 | Buy |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||